Latest Share Purchase Plan News

Austral Resources Australia Ltd has swung from a $24.2 million loss to a $25.3 million profit in the first half of 2026, boosted by strategic acquisitions, capital raises, and operational shifts. The company is advancing its Rocklands restart and has proposed acquiring Hammer Metals to expand its copper footprint.

Paradigm Biopharmaceuticals has surpassed its Phase 3 enrolment target for Zilosul®, secured over A$21 million in capital, and pivots towards clinical evidence generation with major data readouts expected.

Bio-Gene Technology narrowed its loss to $2.33 million in FY26 while progressing key toxicity studies for Flavocide and securing a commercial foothold for Qcide in Japan. The company bolstered its balance sheet with a $3.275 million capital raise to fund ongoing development and production scale-up.

CurveBeam AI has secured nearly half of its A$5 million placement at $0.02 per share, issuing 120 million shares to key investors while awaiting the remainder of funds from Intellivision Holdings.

Saturn Metals has significantly oversubscribed its Share Purchase Plan, raising $21.28 million against a $5 million target. Combined with a recent $100 million placement, the company now has $121.28 million to accelerate development of its Apollo Hill Gold Project in Western Australia.

Weebit Nano surged to record revenue of $15.3 million in FY26, fueled by key licensing deals and product tape-outs, while investing heavily in R&D and AI initiatives. Despite a $54.9 million loss, a $102 million capital raise leaves the company well-positioned for growth.

Argo Global Listed Infrastructure (ASX: ALI) reported a robust FY2026 with total assets rising to $529 million and a record fully franked dividend of 10 cents per share. The portfolio outperformed benchmarks, driven by strong gains in electric utilities and midstream energy sectors amid AI-driven data centre demand.

Syntara Limited’s FY2026 results show a 7.9% revenue decline and a 13.6% increase in net loss amid significant clinical progress, including FDA backing for its lead drug amsulostat and a successful $8.8 million capital raise.

Aeris Resources delivered a standout FY26 with revenues up 22% and profit after tax surging 295%, buoyed by operational gains and a strategic acquisition of Peel Mining.

X2M Connect has landed its first binding contract to deliver a GPU-accelerated AI data centre in Australia, marking a major step into a booming $190 billion market with a project valued at over $250 million.

Acrow Limited secures final ACCC approval for its AusGroup Industrial Services acquisition, clearing the path for completion on 1 September 2026 and strengthening its foothold in Australia’s civil infrastructure sector.

FireFly Metals has raised approximately A$190 million through institutional and bought deal placements, positioning the company to advance its Green Bay Copper-Gold Project with early works, drilling, and feasibility studies ahead of a mid-2027 investment decision.